Bone Biologics (BBLG) Receivables - Other (2014 - 2015)
Bone Biologics (BBLG) reported Receivables - Other of $75000.0 for Q3 2015, down 50.0% quarter-over-quarter from $150000.0 in Q2 2015.
Bone Biologics (BBLG) Receivables - Other (2014 - 2015) Analysis & Trends
Bone Biologics (BBLG) has 2 years of Receivables - Other data on file, last reported at $75000.0 in Q3 2015.
- Receivables - Other for Q3 2015 came in at $75000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2015 was $75000.0 (changed N/A YoY), and the FY2014 annual result was $75000.0, changed N/A from the prior year.
- Receivables - Other eased to $75000.0 in Q3 2015 per BBLG's latest filing, from $150000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $150000.0 in Q2 2015 and troughed at $75000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 75,000.00 |
| Sep 30, 2015 | 75,000.00 |
| Jun 30, 2015 | 150,000.00 |
| Jun 30, 2015 | 150,000.00 |
| Dec 31, 2014 | 75,000.00 |
| Dec 31, 2014 | 75,000.00 |